New prostate cancer diagnoses increased 12.08% and prostate-specific antigen screenings increased 52.18% between 2021 and 2024, according to data published Feb. 12 by Epic Research. Epic’s research division utilized data from Cosmos, a dataset created in collaboration with a community…
Author: Elizabeth Gregerson
Patients with endometrial hyperplasia or benign uterine pathology had a 66% reduced risk of developing endometrial cancer when treated with progestins and a GLP-1 compared to patients treated with progestins alone, according to a study published Feb. 10 in JAMA…
In a move that underscores Duarte, Calif.-based City of Hope’s mission to translate scientific discovery into real-world outcomes, the organization recently appointed Vanessa Almendro Navarro, PhD, as chief commercialization officer. In her role, Dr. Almendro Navarro is at the helm…
The Surgical Review Corporation has named Newport Beach, Calif.-based Hoag the world’s first center of excellence in oncoplastic breast surgery. In a Feb. 11 news release, Nirav Savalia, MD, medical director of oncoplastic and aesthetic breast surgery at Hoag, said…
In April, Bend, Ore.-based St. Charles Health System will open a cancer center in Redmond, Ore., that can serve up to 300 patients per day. The facility will be nine times larger than the system’s current cancer care facilities in…
Orange, Calif.-based UCI Health has expanded the inpatient bed capacity of its stem-cell transplant program by 200% after opening the UCI Health — Irvine (Calif.) medical campus in December. The inpatient suites are designed to facilitate customized cell therapy delivery…
Salt Lake City-based Huntsman Cancer Institute at the University of Utah will be the first U.S. academic medical center to manufacture a novel prostate cancer imaging drug, flotufolastat F 18. The drug was developed by Blue Earth Diagnostics and will…
Three U.S. cancer centers have been recognized by Planetree for providing person-centered care. Planetree is a nonprofit aimed at elevating the patient experience and “humanizing” healthcare, according to the organization’s website. It certifies global healthcare organizations across the care continuum…
As part of CMS’ PPS-Exempt Cancer Hospital Quality Reporting Program, the agency collects data on four palliative care-related measures at 11 cancer hospitals. The four measures related to palliative care are: Lower rates are better for all four measures, according…
The University of Cincinnati Cancer Center has tapped David Gius, MD, PhD, as director. Dr. Gius will step into the role July 1. Dr. Gius most recently served as associate cancer center director for translational research and assistant dean for…
